MAP3K3 and cerebral cavernous malformation: There is some evidence that aberrantly activated MEKK3 signaling can lead to increased RhoA-ROCK signaling, but the exact mechanism for this potential crosstalk and its contribution to CCM disease need to be further elucidated [79,80,85,86].